home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Asian Century and Clinical Trials: Issues for Consideration by Biotechnology Companies

 
  April 25, 2016  
     
 
Xtalks Life Science Webinars, Online
2016-05-19


As with many other industries, there is a prevailing belief that the 21st Century will be the Asian Century when it comes to drug development and the pharmaceutical industry. Already, markets such as China are predicted to overtake the US to become the largest pharmaceutical market in the world during the first half of this century. As the globalization of clinical research gathers pace, the Asian region will continue to grow making it the most exciting frontier for biotechnology and pharmaceutical companies to conduct clinical research in. In a recent Novotech survey of executives from biopharmaceutical companies, 98% of respondents said they would consider the Asia Pacific region for future clinical trials.
 
 
Organized by: Xtalks Life Science Webinars
Invited Speakers:
 
Deadline for Abstracts: 2016-05-19
 
Registration: Free
E-mail: helpdesk@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.